Oncocross Co., Ltd. (KOSDAQ:382150)
6,600.00
-430.00 (-6.12%)
Mar 9, 2026, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 80.49 billion as of March 9, 2026. Its market cap has decreased by -47.89% in one year.
Market Cap
80.49B
Enterprise Value
58.80B
Revenue
884.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
6,600.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has decreased from 106.25B to 80.49B, a decrease of -24.24%. That is a compound annual growth rate of -20.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 80.49B | -30.15% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneOne Life Science | 92.36B |
| Amicogen | 94.41B |
| IMB Dx | 96.02B |
| ORIENT BIO | 68.89B |
| CG Invites | 111.96B |
| MedPacto | 174.46B |
| ENCell | 177.52B |
| Macrogen | 185.06B |